In this preclinical study exploring RT combination strategies, we assess local tumor RT against well-established colorectal adenocarcinoma MC38 and pancreatic ductal adenocarcinoma (PDA) Pan02 and KPC in Sirpα−/− mice. The gene discussed is SIRPA; the disease is Patent ductus arteriosus.